<qa>  What is the name of the PHASE I, OPEN LABEL, NONA PHASE I, OPEN LABEL, NON RANDOMIZED, MULTICENTER, DOSE ESCALATION CLINICAL STUDY TO INVESTIGATE SAFETY AND TOLERABILITY OF OPBOTSUKA PHARMACEUTICAL BIWA-111077 IN SUBJECTS WITH ADVANCED HCCHEPATOCELLULAR CARCINOMA: 